When designing a sterile injectable suspension, which set of considerations is most comprehensive?

• A. Sterility assurance alone is sufficient.
• B. Emphasize only viscosity; other factors are unimportant.
• C. Buffering capacity is the only concern.
• D. Sterility assurance, particle size control, suspension stability and sedimentation, isotonicity and pH compatibility, viscosity for injection, and appropriate preservatives for multi-dose products.

Answer: (D)

A sterile injectable suspension must satisfy multiple interrelated quality attributes rather than a single property. Sterility assurance is essential to prevent microbial contamination, but safety and effectiveness also depend on how the product behaves once administered. Particle size and distribution matter for uniform dosing, bioavailability, and reducing safety risks from large or inconsistent particles. Suspension stability and sedimentation describe how well the particles stay evenly dispersed over time and how easily the mixture can be re-suspended before injection, which affects dose uniformity and patient experience. Isotonicity and pH compatibility are important for minimizing irritation to tissues and ensuring chemical stability of the drug and excipients in the physiological environment. Viscosity for injection influences how easily the product can be drawn into a syringe and pushed through a needle, affecting patient comfort and dosing accuracy. For multi-dose products, appropriate preservatives are needed to prevent microbial growth between uses. Together, these factors form a comprehensive design approach that supports safety, efficacy, and usability of sterile injectable suspensions.